Comparison of gastric emptying and plasma ghrelin levels in patients with functional dyspepsia and non-erosive reflux disease

Digestion

Volumn 79, Issue 2, 2009, Pages 65-72

  Shindo, Tomotaka ^a   Futagami, Seiji ^a   Hiratsuka, Tetsuro ^a   Horie, Akane ^a   Hamamoto, Tatsuhiko ^a   Ueki, Nobue ^a   Kusunoki, Masafumi ^a   Miyake, Kazumasa ^a   Gudis, Katya ^a   Tsukui, Taku ^a   Iwakiri, Katsuhiko ^a   Sakamoto, Choitsu ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Dyspepsia, functional; Gastric emptying; Gastric motility; Ghrelin, acylated; Non erosive reflux disease

Indexed keywords

GHRELIN;

ADULT; ARTICLE; CONTROLLED STUDY; DYSPEPSIA; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIGASTRIC PAIN; FEMALE; GASTROINTESTINAL REFLUX; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; POSTPRANDIAL STATE; PRIORITY JOURNAL; STOMACH EMPTYING; STOMACH MOTILITY; UREA BREATH TEST;

ACYLATION; ADULT; BREATH TESTS; CARBON ISOTOPES; CASE-CONTROL STUDIES; DYSPEPSIA; FEMALE; GASTRIC EMPTYING; GASTRIC MUCOSA; GASTROESOPHAGEAL REFLUX; GHRELIN; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED;

EID: 60749116316     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000205740     Document Type: Article

References (51)

1. Fischer H, Heidemann T, Hengst K, Domschke W, Konturek JW: Disturbed gastric motility and pancreatic hormone release in diabetes mellitus. J Physiol Pharmacol 1998; 49: 529-541.
2. Quigley EM: Gastric emptying in functional gastrointestinal disorders. Aliment Pharmacol Ther 2004; 20(suppl 7):56-60.
3. Tack J, Talley NJ, Camilleri M, Holtmann G, Hu P, Malagelada JR, Stanghellini V: Functional gastroduodenal disorders. Gastroenterology 2006; 130: 1466-1479.
4. Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelada JR, Tytgat GN: Functional gastroduodenal disorders. Gut 1999; 45(suppl 2):II37-II42.
5. Quigley EMM: Gastric motor and sensory function, and motor disorders of the stomach; in Feldman M, Friedman LS, Sleisenger MH (eds): Gastrointestinal and Liver Disease: Pathophysiology/Diagnosis/Management. Philadelphia, Saunders, 2002, pp 691-714.
6. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K: Ghrelin is a growthhormone- releasing acylated peptide from stomach. Nature 1999; 402: 656-660.
7. Masuda Y, Tanaka T, Inomata N, Ohnuma N, Tanaka S, Itoh Z, Hosoda H, Kojima M, Kangawa K: Ghrelin stimulates gastric acid secretion and motility in rats. Biochem Biophys Res Commun 2000; 276: 905-908.
8. Asakawa A, Inui A, Fujimiya M, Sakamaki R, Shinfuku N, Ueta Y, Meguid MM, Kasuga M: Stomach regulates energy balance via acylated ghrelin and desacyl ghrelin. Gut 2005; 54: 18-24.
9. Chen CY, Chao Y, Chang FY, Chien EJ, Lee SD, Doong ML: Intracisternal des-acyl ghrelin inhibits food intake and non-nutrient gastric emptying in conscious rats. Int J Mol Med 2005; 16: 695-699.
10. Drossman DA: The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006; 130: 1377-1390.
11. Dickman R, Bautista JM, Wong WM, Bhatt R, Beeler JN, Malagon I, Risner-Adler S, Lam KF, Fass R: Comparison of esophageal acid exposure distribution along the esophagus among the different gastroesophageal reflux disease groups. Am J Gastroenterol 2006; 101: 2463-2469.
12. Dixon MF, Genta RM, Yardley JH, Correa P: Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20: 1161-1181.
13. Hellmig S, Von Schoning F, Gadow C, Katsoulis S, Hedderich J, Folsch UR, Stuber E: Gastric emptying time of fluids and solids in healthy subjects determined by 13 C breath tests: influence of age, sex and body mass index. J Gastroenterol Hepatol 2006; 21: 1832-1838.
14. Talley NJ, Zinsmeister AR, Schleck CD, Melton LJ 3rd: Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology 1992; 102: 1259-1268.
15. Castillo EJ, Camilleri M, Locke GR, Burton DD, Stephens DA, Geno DM, Zinsmeister AR: A community-based, controlled study of the epidemiology and pathophysiology of dyspepsia. Clin Gastroenterol Hepatol 2004; 2: 985-996.
16. Tack J, Piessevaux H, Coulie B, Caenepeel P, Janssens J: Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 1998; 115: 1346-1352.
17. Lunding JA, Tefera S, Gilja OH, Hausken T, Bayati A, Rydholm H, Mattsson H, Berstad A: Rapid initial gastric emptying and hypersensitivity to gastric filling in functional dyspepsia: effects of duodenal lipids. Scand J Gastroenterol 2006; 41: 1028-1036.
18. Moayyedi P, Deeks J, Talley NJ, Delaney B, Forman D: An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in nonulcer dyspepsia: resolving the discrepancy between systematic reviews. Am J Gastroenterol 2003; 98: 2621-2626.
19. Armstrong D: Helicobacter pylori infection and dyspepsia. Scand J Gastroenterol 1996; 215: 38-47.
20. Strauss RM, Wang TC, Kelsey PB, Compton CC, Ferraro MJ, Perez-Perez G, Parsonnet J, Blaser MJ: Association of Helicobacter pylori infection with dyspeptic symptoms in patients undergoing gastroduodenoscopy. Am J Med 1990; 89: 464-469.
21. Talley NJ, Janssens J, Lauritsen K, Racz I, Bolling-Sternevald E: Eradication of Helicobacter pylori in functional dyspepsia: randomized double blind placebo controlled trial with 12 months' follow up. BMJ 1999; 318: 833-837.
22. McColl K, Murray L, El-Omar E, Dickson A, El-Nujumi A, Wirz A, Kelman A, Penny C, Knill-Jones R, Hilditch T: Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia. N Engl J Med 1998; 339: 1869-1874.
23. Quartero AO, de Wit NJ, Lodder AC, Numans ME, Smout AJ, Hoes AW: Disturbed solid-phase gastric emptying in functional dyspepsia: a meta-analysis. Dig Dis Sci 1998; 43: 2028-2033.
24. Tack J, Bisschops R, Sarnelli G: Pathophysiology and treatment of functional dyspepsia. Gastroenterology 2004; 127: 1239-1255.
25. Sarnelli G, Caenepeel P, Geypens B, Janssens J, Tack J: Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia. Am J Gastroenterol 2003; 98: 783-788.
26. Shi G, Bruley des Varannes S, Scarpignato C, Le Rhun M, Galmiche JP: Reflux related symptoms in patients with normal oesophageal exposure to acid. Gut 1995; 37: 457-464.
27. Fass R, Naliboff B, Higa L, Johnson C, Kodner A, Munakata J, Ngo J, Mayer EA: Differential effect of long-term esophageal acid exposure on mechanosensitivity and chemosensitivity in humans. Gastroenterology 1998; 115: 1363-1373.
28. Kamolz T, Velanovich V: Psychological and emotional aspects of gastroesophageal reflux disease. Dis Esophagus 2002; 15: 199-203.
29. Jones MP, Roth LM, Crowell MD: Symptom reporting by functional dyspeptics during the water load test. Am J Gastroenterol 2005; 100: 1334-1339.
30. Kovacs Z, Kerekgyarto O: Psychological factors, quality of life, and gastrointestinal symptoms in patients with erosive and nonerosive reflux disorder. Int J Psychiatry Med 2007; 37: 139-150.
31. Venables TL, Newland RD, Patel AC, Hole J, Wilcock C, Turbitt ML: Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice. Scand J Gastroenterol 1997; 32: 965-973.
32. Fass R, Ofman JJ: Gastroesophageal reflux disease - should we adopt a new conceptual framework? Am J Gastroenterol 2002; 97: 1901-1909.
33. Martinez SD, Malagon IB, Garewal HS, Cui H, Fass R: Non-erosive reflux disease (NERD) - acid reflux and symptom patterns. Aliment Pharmacol Ther 2003; 17: 537-545.
34. Carmagnola S, Fraquelli M, Cantu P, Conte D, Penagini R: Relationship between acceleration of gastric emptying and oesophageal acid exposure in patients with endoscopynegative gastro-oesophageal reflux disease. Scand J Gastroenterol 2006; 41: 767-772.
35. Scheffer RC, Tatum RP, Shi G, Akkermans LM, Joehl RJ, Kahrilas PJ: Reduced tLESR elicitation in response to gastric distension in fundoplication patients. Am J Physiol Gastrointest Liver Physiol 2003; 284:G815- G820.
36. Penagini R, Carmagnola S, Cantu P, Allocca M, Bianchi PA: Mechanoreceptors of the proximal stomach: role in triggering transient lower esophageal sphincter relaxation. Gastroenterology 2004; 126: 49-56.
37. Zerbib F, Bicheler V, Leray V, Joubert M, Bruley des Varannes S, Galmiche JP: H. pylori and transient lower esophageal sphincter relaxations induced by gastric distension in healthy humans. Am J Physiol Gastrointest Liver Physiol 2001; 281:G350-G356.
38. Trudel L, Tomasetto C, Rio MC, Bouin M, Plourde V, Eberling P: Ghrelin/motilin-related peptide is a potent prokinetic to reverse gastric postoperative ileus in rat. Am J Physiol Gastrointest Liver Physiol 2002; 282: G948-G952.
39. Herculano JR Jr, Troncon LE, Aprile LR, Morases ER, Secaf M, Onofre PH, Dantas RO, Oliveira RB: Diminished retention of food in the proximal stomach correlates with increased acidic reflux in patients with gastroesophageal reflux disease and dyspeptic symptoms. Dig Dis Sci 2004; 49: 750-756.
40. Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, Dhillo WS, Ghatei MA, Bloom SR: Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 2001; 86: 5992.
41. Tack J, Depoortere I, Biosschops R, Verbeke K, Janssens J, Peeters T: Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis. Aliment Pharmacol Ther 2005; 22: 847-853.
42. Tack J, Deoportere I, Bisschops R, Delporte C, Coulie B, Meulemans A, Janssens J, Peeters T: Influence of ghrelin on interdigestive gastrointestinal motility in humans. Gut 2006; 55: 327-333.
43. Shinomiya T, Fukunaga M, Akamizu T, Irako T, Yokode M, Kangawa K, Nakai Y, Nakai Y: Plasma acylated ghrelin levels correlate with subjective symptoms of functional dyspepsia in female patients. Scand J Gastroenterol 2005; 40: 648-653.
44. Takamori K, Mizuta Y, Takeshima F, Akazawa Y, Isomoto H, Ohnita K, Ohba K, Omagari K, Shikuwa S, Kohno S: Relation among plasma ghrelin level, gastric emptying, and psychologic condition in patients with functional dyspepsia. J Clin Gastroenterol 2007; 41: 477-483.
45. Lanzini A, Magni P, Petroni ML, Motta M, Lanzarotto F, Villanacci V, Amato M, Mora A, Bertolazzi S, Benini F, Ricci C: Circulating ghrelin level is increased in coeliac disease as in functional dyspepsia and reverts to normal during gluten-free diet. Aliment Pharmacol Ther 2006; 23: 907-913.
46. Masuda Y, Tanaka T, Inomata N, Ohnuma N, Tanaka S, Itoh Z, Hosoda H, Kojima M, Kangawa K: Ghrelin stimulates gastric acid secretion and motility in rats. Biochem Biophys Res Commun 2000;276: 905-908.
47. Kitazawa T, De Smet B, Verbeke K, Depoortere I, Peeters TL: Gastric motor effects of peptide and non-peptide ghrelin agonists in mice in vivo and in vitro. Gut 2005; 54: 1078-1084.
48. Trudel L, Tomasetto C, Rio MC, Bouin M, Plourde V, Eberling P, Poitras P: Ghrelin/ motilin-related peptide is a potent prokinetic to reverse gastric postoperative ileus in rat. Am J Physiol Gastrointest Liver Physiol 2002; 282:G948-G952.
49. Osawa H, Nakazato M, Date Y, Kita H, Ohnishi H, Ueno H, Shiiya T, Satoh K, Ishino Y, Sugana K: Impaired production of gastric ghrelin in chronic gastritis associated with Helicobacter pylori. J Clin Endocrinol Metab 2005; 90: 10-16.
50. Suzuki H, Masaoka T, Hosoda H, Nomura S, Ohara T, Kangawa K, Ishii H, Hibi T: Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio - a possible novel and non-invasive marker for gastric atrophy. Hepatogastroenterology 2004; 51: 1249-1254.
51. Rashed H, Cutts T, Abell T, Cowings P, Toscano W, El-Gammal A, Adl D: Predictors of response to a behavioral treatment in patients with chronic gastric motility disorders. Dig Dis Sci 2002; 47: 1020-1026.